I’m stating the obvious using the companies own asx announcements for reference.
It works out to a $200 million shortfall.
- Forums
- ASX - By Stock
- SAS
- Ann: Completion of Pearls Critical Design Review
Ann: Completion of Pearls Critical Design Review, page-29
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online